INTRODUCTION
In the last decades, various peptide hormones from the gastrointestinal (GI) tract have been identified to play a role in the short-term regulation of food intake and satiety by altering the initiation and termination of meals (62). We previously demonstrated in rats that cholecystokinin-8S (CCK) abolished the orexigenic effect of peripherally administered ghrelin and blocked activation of ghrelin sensitive neurons in the hypothalamic arcuate nucleus (ARC) (30) . In addition, peripheral interaction of ghrelin with CCK on feeding regulation was no longer observed in rats with disrupted CCK A receptor (18) .
Bombesin is a tetradecapeptide that was first isolated in 1971 from the amphibian skin of a European toad Bombina bombina (1) . In mammals, several bombesin-like peptides exist with structural homology to bombesin, including the mammalian peptides, gastrin releasing peptide (GRP), and neuromedin B (43) . Bombesin binds with high affinity to GRP (BB 2 ) and neuromedin B (BB 1 ) receptors, which are widely spread in the gastrointestinal tract and also in the central nervous system (CNS) (43) . Bombesin-like peptides are released in the gastric mucosa in response to nutrients (56). It is well established that peripheral or central administration of bombesin or GRP suppresses food intake through interactions with both BB 1 and BB 2 receptors in a variety of species, including humans (19;23;32;41;43;64;69) .
Another satiety peptide released from the gastrointestinal tract is amylin, a 37-amino acid peptide produced by pancreatic ß-cells that is secreted into the blood stream after food intake (50) . Peripheral administration of amylin suppresses food intake in rats and mice (9;20;38;45;75) . Convergent studies established that amylin-induced decreased feeding behavior involves neurons of the area postrema (AP) (39) , a circumventricular organ of the brainstem (40) where amylin receptors are located in high density (58), while afferent vagal nerve fibers do not play a role (36) .
Ghrelin is a 28-amino acid peptide hormone mainly produced in X/A-like cells in the mucosal layer of the stomach (16;31;73) . Ghrelin is the first gut-brain peptide being identified Page 3 of 46 R-00681-2005.R2 to stimulate food intake in rats (46;66;71;72) , mice (4;67) , and humans (70) . The potent orexigenic effect of peripheral administration of ghrelin (46;66;71;72) , the rise in plasma ghrelin levels induced by food deprivation, weight loss or before a meal (14) , (66) , and the reduction of feeding in response to central administration of growth hormone secretagogue receptor (GHS-R) antagonist (3) in rodents implicate endogenous ghrelin in the initiation of food intake (13) . In sharp contrast to ghrelin, bombesin elicits anorexigenic effects and is involved in meal termination (19;23;32;41;64;69) . Recent studies indicate that vagal afferents-dependent mechanisms may be involved in peripheral injection of ghrelin-induced increase in food intake and Fos-like immunoreactivity (FLI) in the arcuate nucleus of the hypothalamus (ARC), as demonstrated by the attenuation of the spontaneous feeding behavior induced by ghrelin after surgical deafferentiation of the vagal nerve (17) . This contrasts with the inhibitory effect of bombesin on food intake that is mainly mediated by spinal afferent nerve fibers (42) , and is not solely dependent on afferent vagal nerve fiber integrity (21;61).
Ghrelin, bombesin, and amylin injected peripherally induce neuronal activation in different brain areas involved in regulation of satiety and hunger, as shown by the induction of the immediate early gene product Fos, a marker indicating neuronal activation in a specific brain area. Ghrelin administered ip induces c-fos expression in the ARC in rats and mice (25;30;67) and in the paraventricular nucleus of the hypothalamus (PVN) in rats (30;52) . Double labeling showed that peripheral injection of ghrelin activates neurons containing the orexigenic peptides neuropeptide Y (NPY)/Agouti-related protein present in the ARC (67) .
Peripheral injection of bombesin induces FLI in the PVN, nucleus tractus solitarius (NTS), and the AP (7;34) . In this context, it is of interest that icv administration of bombesin influences the hypothalamic corticotropin releasing factor (CRF) system as shown by the stimulation of CRF release in the hypothalamus (27;28;47) . Activation of hypothalamic CRF plays a key role in the endocrine and anxiogenic responses to stress (5) as well as in other Peripheral administration of amylin induces c-fos expression in neurons of the AP, NTS, lateral parabrachial nucleus (PBN), and in the central nucleus of the amygdala (49) where numerous reciprocal projections exist. Riediger et al. (49) reported that fasting in rats increased Fos positive neurons in the lateral hypothalamus (LHA) that are reduced by peripheral administration of amylin (49) .
Collectively these findings provide the framework for an antagonistic interaction between ghrelin and bombesin or amylin to regulate food intake. Therefore, in the present study, we investigated whether peripheral bombesin or amylin modulate the orexigenic effects of peripheral ghrelin in freely fed male rats. At first, we examined whether bombesin and amylin alter dose-dependently the orexigenic effect of ghrelin. Furthermore, after simultaneous injection of ghrelin and bombesin, we investigated the pattern of c-fos expression in the PVN, ARC and NTS. Brain nuclei were selected based on the presence of growth hormone secretagogue receptors (GHS-R), the cognate receptor for ghrelin (ARC, PVN) (22) , and GRP (BB 2 )-receptors (NTS, PVN) for bombesin-induced suppression of food intake (43) . Additionally, the neuropeptidergic phenotype of Fos positive neurons in the PVN was analyzed after simultaneous administration of ghrelin and bombesin in relation with the activation of CRF neurons. 
MATERIALS AND METHODS

ANIMALS
Male Sprague-Dawley rats (Harlan-Winkelmann Co., Borchen, Germany) weighing 250-300 g were housed in groups of 4 rats/cage under conditions of controlled illumination (12:12 h light/dark cycle, lights on/off: 6:30 a.m./6:30 p.m.), humidity, and temperature (22 ± 2°C).
Animals were fed with a standard rat diet (Altromin ® , Lage, Germany) and tap water ad libitum. All animals were trained daily to be accustomed to the experimental conditions for 14 days before starting the experiments. During the handling phase, the back position was practiced to make animals familiar with receiving an intraperitoneal (ip) injection.
Furthermore, every day, animals were removed from their social group for 2 h and set in single cages. This period of social isolation mimics the time schedule of the experiments.
Animals used for neuronal mapping (Fos-LI) were handled daily for 5 days before the start of the experiment and similarly trained to be held in the back position for ip injection.
Animal care and experimental procedures followed institutional ethic guidelines and conformed to the requirements of the state authority for animal research conduct under the protocol G0089/02.
Peptide preparation
Rat ghrelin (Bachem AG, Heidelberg, Germany) and bombesin (Bachem AG) were dissolved in distilled water and stored at -20°C. Rat amylin (Bachem AG) was dissolved in 0.1% trifluoroacetic acid (Merck, Darmstadt, Germany). Immediately before starting the experiments, peptides were diluted in vehicle solution consisting of sterile 0.15M NaCl (Braun, Melsungen, Germany) to reach the final concentration of 13 µg/kg (~4 nmol/kg) for 
Experimental protocols
If not otherwise stated, all experiments were performed at the same time of the day (between 08:00 h-11:00 h), at 1.5 to 4.5 h after the start of the light cycle in freely fed rats to achieve maximum consistency. At that time period freely fed rats have their lowest food intake.
Effects of ghrelin and bombesin injected ip singly or in combination on food intake.
Rats were injected ip simultaneously (final volume: 0.5 ml) with vehicle plus vehicle (0.15M NaCl + 0.15M NaCl, n=20), ghrelin plus vehicle (13 µg/kg + 0.15M NaCl, n=20), vehicle plus bombesin (0.15M NaCl + 4 (n=15) or 8 (n=15) µg/kg), or ghrelin plus bombesin (13 µg/kg + 4 (n=15) or 8 (n=15) µg/kg) and returned to single housing cages immediately after the injection. Thereafter, pre-weighed rat chow was made available to the animals. Food intake was determined by measuring the difference between the pre-weighed standard chow and the weight of chow at the end of the first 30 min, 1 h and 2 h periods of food exposure. Doses of peptides selected were based on previous studies (30;42) .
Effects of ghrelin and amylin injected ip singly or in combination on food intake. The experimental protocol was performed as described in experiment 1. Freely fed rats were injected ip simultaneously (final volume: 0.5 ml) with vehicle plus vehicle (0.15M NaCl + 0.15M NaCl, n=10), ghrelin plus vehicle (13 µg/kg + 0.15M NaCl, n=10), vehicle plus amylin (0.15M NaCl + 1 (n=10) or 5 (n=10) µg/kg), or ghrelin plus amylin (13 µg/kg + 1 (n=10) or 5 (n=10) µg/kg) and returned to single housing cages immediately after the injection.
Thereafter, pre-weighed rat chow was made available to the animals. Food intake was Sections were rinsed in PBS three times again, then embedded in anti-fading solution and analyzed using a confocal laser scanning microscope.
Data and statistical analysis
Immunohistochemistry. Semi-quantitative assessment of FLI was achieved by counting the number of FLI positive cells as described before (30) . Cells with green nuclear Feeding experiments. The cumulative food intake monitored at the end of the first 30 min, 1 h and 2 h periods after peptide or vehicle injection was expressed as food intake (g)/body weight (kg) (30) . Data are expressed as mean ± SEM and analyzed by ANOVA.
Differences between groups were evaluated by the Least Significant Difference test; p < 0.05 was considered significant.
The cumulative food intake in the control experiment with 5 µg amylin/kg ip monitored at the end of the first 30 min and 1 h periods after peptide administration in the dark phase was also expressed as food intake (g)/body weight (kg). Data are expressed as 
RESULTS
Effects of ghrelin and bombesin injected ip singly or in combination on food intake
Within the first half hour, ghrelin (13 µg /kg, ip) significantly increased food intake compared to the ip vehicle plus vehicle group (g/kg: 3.66 ± 0.80 vs. 1.68 ± 0.42; p < 0.0087; (Fig. 1) . One hour after ghrelin administration, the cumulative food intake was still significantly increased compared to the vehicle plus vehicle group (4.78 ± 0.84 vs. 2.72 ± 0.64 g/kg, p < 0.044; Fig. 1 ) while all other groups were not statistically significant different from the control vehicle group (Fig. 1) . Two hours after ghrelin plus vehicle injection, the cumulative food intake was still significantly higher than in the ghrelin plus 8 µg/kg bombesin group (6.18 ± 1.16 vs. 1.63 ± 0.46 g/kg, p < 0.0007; Fig. 1 ) and the vehicle plus 8 µg/kg bombesin group (2.39 ± 1.23 g/kg, p < 0.0045; Fig. 1 ) but no longer significant compared with vehicle plus vehicle group. Both doses of bombesin injected with vehicle did not significantly alter the 1 or 2 h cumulative food intake compared to the control animals injected with vehicle ( Fig. 1) .
Effects of ghrelin and amylin injected ip singly or in combination on food intake
Within the first half hour, ghrelin (13 µg/kg, ip) significantly increased food intake compared to the ip vehicle plus vehicle group (g/kg: 3.96 ± 0.56 vs. 0.82 ± 0.59; p < 0.004; Fig. 2) . At 1 and 2 h after ghrelin ip administration, we observed significant changes in cumulative food intake only between the ghrelin group and both doses of amylin alone (Fig. 2) . Further, both doses of amylin alone showed a non-significant trend to decrease food intake during these time intervals compared to the vehicle plus vehicle group (Fig. 2) .
Effect of 5 µg amylin on food intake injected ip at the beginning of the dark phase.
Amylin injected ip alone at 5 µg/kg resulted in a statistically non-significant reduction in food intake during the first half hour compared to the vehicle treated group (7.01 ± 0.89 vs. 9.25 ± 0.8 g/kg, p > 0.09; Fig. 3 ). One hour after amylin injection, the cumulative food intake was significantly decreased in the amylin group compared to the control group (7.01 ± 0.89 vs. 10.06 ± 0.6 g/kg, p < 0.016; Fig. 3 ). (Fig. 8b) . Further, we observed that 45.4 ± 10.6 % of Fos neurons in the PVN induced by ghrelin (13µg/kg, ip) alone were also CRF positive (Fig. 8a) . Ghrelin ip at this dose induced Fos expression in 10.3 ± 1.9 % of CRF-immunoreactive neurons in the PVN (Fig. 8b) .
Effects of ghrelin and bombesin injected ip singly or in combination on
Nucleus of the solitary tract:
In the NTS, bombesin (8 µg/kg) injected ip alone or with ghrelin (13µg/kg) increased the number of FLI-positive neurons ~1.5-fold compared to the vehicle group (Fig. 9 ). All other treatments did not have any significant effect on c-fos expression in the NTS (Fig. 9 ). (6) . In the present study, we provide evidence that peripheral bombesin, when administered simultaneously with ghrelin, blocks the orexigenic action of ip administered ghrelin in freely fed rats previously accustomed to the experimental conditions. In contrast, peripheral amylin did not influence the orexigenic effect of ghrelin under the same conditions.
These findings suggest that interactions between GI peptides involved in the regulation of food intake are peptide specific. In parallel with these behavioral observations, ip ghrelin plus bombesin -but not ip amylin -affects neuronal activity in the hypothalamus. In particular, we found that the increase of FLI in the PVN was 1.5-fold more pronounced after coadministration of ghrelin plus bombesin compared with that of ghrelin alone, while bombesin injected singly had no effect on neuronal activity in this brain nucleus.
Ghrelin (13 µg/kg ip) stimulated feeding behavior in freely fed rats resulted in a more than 100% increase in the amount of food ingested during the first 30 min after peripheral injection of the peptide. The response lasted for 1 h and was no longer observed after 2 h consistent with the rapid and short-live orexigenic action of peripherally injected ghrelin in rodents and humans and its function in short-term regulation of feeding (30;46;66;67;71;72).
In addition, we observed that co-injection of bombesin (8 µg/kg, ip) inhibited ghrelin-induced increase in food intake within the first 30 min. The inhibitory effect was long lasting, as
shown by significantly reduced food intake in the bombesin plus ghrelin group compared to vehicle plus ghrelin throughout the 2-h experimental period.
We previously demonstrated a comparable long-lasting inhibition of ghrelin-induced food intake by simultaneous peripheral injection of CCK (30) The doses of amylin (1 and 5 µg/kg) used in the present study did not significantly alter food intake in non-fasted rats under these experimental conditions. However, these doses were reported to be efficient to decrease food intake in food-deprived rats (35;36) . intake in fasted and non-fasted rats during the early light phase (37) . In the present study no significant reduction in food intake at administration of amylin in comparison to vehicle treated animals was observed during the light phase. However, during the first and second hour after amylin administration alone, we observed a trend toward a reduction in cumulative food intake, although this effect did not reach statistical significance. Therefore, it is feasible that the duration of the observation phase in this study was too short to uncover the effect of amylin on food intake during the early light phase.
The observed activation of neurons in the ARC in response to peripheral injection of ghrelin is consistent with previous studies in mice and rats (25;30;67) . Furthermore, it has been reported that ARC neurons activated by peripheral ghrelin contain NPY, a wellestablished orexigenic peptide (67) . Convergent evidence supports a role of NPY projections from the ARC to the PVN in the orexigenic effect of peripheral ghrelin on food intake (15) . In particular, we previously showed that peripheral ghrelin induces c-fos expression in the PVN (52), which was confirmed in the present study. Likewise, desacyl ghrelin induces a change of neuronal activity in the ARC and PVN (2).
Systemic administration of bombesin at a dose of 10 µg/kg induces c-fos expression in the PVN in fed or fasted rats (7;34) . After the ip administration of bombesin, at doses of 4 and 8 µg/kg, we observed no changes of c-fos expression in the PVN. This difference in c-fos expression might be explained by differences in peptide doses or in the metabolic status of freely fed versus fasted rats in our previous study (7) . Fasting is known to activate ARC neurons projecting to the PVN (68), which may increase their responsiveness to peripheral bombesin under fasted versus fed conditions. Nevertheless, compared to control animals, neurons in the NTS expressed significantly higher levels of Fos after bombesin-injected ip at 8 µg/kg alone or with ghrelin compared with vehicle group. This is in good agreement with previous reports (7) and may contribute to the higher expression of Fos in the PVN in bombesin plus ghrelin treated rats since NTS neurons project the PVN (34;55). antibodies reduced food intake in rats (65) . Therefore, the activation of CRF neurons by ghrelin could point out a regulatory counter mechanism, which terminates food intake. receptor (33) . Consequently, we can rule out that bombesin-induced inhibition of ghrelininduced food intake is primarily mediated by directly influencing the afferent vagal nerve or that bombesin action is secondary to peripheral bombesin-induced CCK release (11) .
In a previous study we observed that CCK alone administered peripherally, without ghrelin, in freely fed animals did not significantly inhibit food intake (30) . We observed the same lack of effect on food intake in the present study for bombesin and amylin. Most studies
showing an inhibitory effect of peripheral bombesin or amylin on food intake were conducted in fasted animals to assess the termination of hyperphagia induced by a fast in animals (40;42) . Thus, the non-fasting state of the animals is very likely the reason for the lack of a significant reduction of food intake during treatment with bombesin or amylin alone in the present study. On the other hand, the time point (light or dark phase) of injection also seems to be important for the physiological action of GI satiety peptides, as demonstrated in the present study for amylin. However, under these experimental conditions it was possible to demonstrate the stimulating effect of ghrelin on food intake as well as its inhibition by GI satiety peptides.
In summary, the present data show that the orexigenic effect of peripheral ghrelin is ghrelin, and vs. ghrelin plus 4 µg bombesin/kg; # p < 0.05 vs. vehicle, vs. ghrelin, and vs.
